华绿生物
(300970)
| 流通市值：15.29亿 | | | 总市值：19.76亿 |
| 流通股本：1.24亿 | | | 总股本：1.60亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 998,862,425.82 | 693,881,412.3 | 414,243,699.16 | 1,291,890,340.95 |
| 营业收入 | 998,862,425.82 | 693,881,412.3 | 414,243,699.16 | 1,291,890,340.95 |
| 二、营业总成本 | 1,004,812,017.98 | 636,029,193.71 | 297,997,767.92 | 1,179,931,454.88 |
| 营业成本 | 919,088,486.82 | 586,745,722.56 | 281,135,029.26 | 1,083,907,393.68 |
| 税金及附加 | 755,563.99 | 526,999.56 | 227,482.41 | 791,377.64 |
| 销售费用 | 11,146,185.7 | 7,034,670.81 | 2,887,448.59 | 10,473,593.71 |
| 管理费用 | 56,680,612.41 | 36,288,538.85 | 14,041,849.88 | 58,830,903.55 |
| 研发费用 | 16,039,331.39 | 8,974,781.48 | 3,646,290.12 | 17,368,705.95 |
| 财务费用 | 1,101,837.67 | -3,541,519.55 | -3,940,332.34 | 8,559,480.35 |
| 其中:利息费用 | 15,521,253.2 | 10,541,376.9 | - | 15,970,456.41 |
| 其中:利息收入 | 14,439,521.45 | 14,099,890.21 | - | 7,442,420.28 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 265,972.61 | 248,986.31 | - | - |
| 资产处置收益 | -1,713,122.36 | 102,977.56 | 101,081.15 | -2,147,494.3 |
| 资产减值损失(新) | -8,476,618.64 | -8,450,277.54 | 107,757.18 | 151,765.13 |
| 信用减值损失(新) | 340,483.5 | 339,191.49 | - | -80,456.62 |
| 其他收益 | 8,683,620.75 | 5,523,166.48 | 2,788,328.11 | 13,977,493.26 |
| 四、营业利润 | -6,849,256.3 | 55,616,262.89 | 119,243,097.68 | 123,860,193.54 |
| 加:营业外收入 | 575,226.87 | 379,191.69 | 153,767.54 | 577,208.43 |
| 减:营业外支出 | 984,238.48 | 236,824.97 | 125,150.13 | 5,132,322.96 |
| 五、利润总额 | -7,258,267.91 | 55,758,629.61 | 119,271,715.09 | 119,305,079.01 |
| 减:所得税费用 | -39,681.35 | -40,366.08 | - | 49,311.04 |
| 六、净利润 | -7,218,586.56 | 55,798,995.69 | 119,271,715.09 | 119,255,767.97 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | - | - | - | 119,255,767.97 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -18,958,153.58 | 46,096,252.7 | 109,891,608.16 | 110,268,302.23 |
| 少数股东损益 | 11,739,567.02 | 9,702,742.99 | 9,380,106.93 | 8,987,465.74 |
| 扣除非经常损益后的净利润 | -18,993,019.65 | 44,558,669.31 | 109,567,475.54 | 112,747,362.5 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.12 | 0.29 | 0.91 | 0.93 |
| (二)稀释每股收益 | -0.12 | 0.29 | 0.91 | 0.93 |
| 九、综合收益总额 | -7,218,586.56 | 55,798,995.69 | 119,271,715.09 | 119,255,767.97 |
| 归属于母公司股东的综合收益总额 | -18,958,153.58 | 46,096,252.7 | 109,891,608.16 | 110,268,302.23 |
| 归属于少数股东的综合收益总额 | 11,739,567.02 | 9,702,742.99 | 9,380,106.93 | 8,987,465.74 |
| 公告日期 | 2026-10-23 | 2026-08-20 | 2026-04-22 | 2026-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |